Press release
Headache Disorders Market Analysis 2024-2033 : Forecast Market Size, Top Segments And Largest Region | Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Novartis AG, Eli Lilly and Company
Headache Disorders Global Market Report
Headache Disorders Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region
Global Headache Disorders Market Comprehensive Study: Forecasted Market Size And Growth Rate
Headache Disorders Market Outlook 2024: Exclusive Report By The Business Research Company
Headache Disorders Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Headache Disorders Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The headache disorders market size has grown strongly in recent years. It will grow from $4.37 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to limited treatment options, growing awareness, rising incidence of headaches, evolving healthcare infrastructure, shift in lifestyle and stress levels.
The headache disorders market size is expected to see strong growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to digital health solutions, personalized medicine approaches, increasing research and development investments, global aging population, expansion of research in neuroinflammation. Major trends in the forecast period include technological advancements in treatment, personalized medicine, increased focus on preventive therapies, expanding pipeline of novel therapies, rise in non-pharmacological approaches.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9452&type=smp
Market Segmentation:
The headache disorders market covered in this report is segmented -
1) By Type: Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types
2) By Treatment: Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy
3) By Diagnosis: Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Major Driver - Rising Prevalence Of Migraine Fuels Growth In The Headache Disorders Market
The increasing prevalence of migraine is expected to propel the growth of the headache disorders market going forward. Migraine refers to a type of headache that is characterized by recurring episodes of moderate to severe throbbing and pulsating pain on one side of the head. Headache disorders can cause neurological disorders causing crippling throbbing pain, tiredness, and nausea that may cause migraine. For instance, according to Migraine.com, part of US-based Health Union, LLC which provide people living with chronic conditions the information, connection, and validation they seek, in 2021, around 39 million people in the United States and 1 billion people worldwide have migraine. Therefore, the increasing prevalence of migraine is driving the demand for the headache disorders market.
Competitive Landscape:
Major companies operating in the headache disorders market report are Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., Amgen Inc., Mylan N.V., Pfizer Inc., GlaxoSmithKline plc, Allergan plc, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eisai Co. Ltd., Impax Laboratories LLC, Lannett Company Inc., Lupin Pharmaceuticals Inc. .
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/headache-disorders-global-market-report
Top Trend - Innovative Products Drive Growth In Headache Disorder Market
Product innovation is a key trend gaining popularity in the headache disorder market. Major companies operating in the headache disorder market are focused on developing innovative products to strengthen their position in the market. For instance, in September 2021, AbbVie, a US-based pharmaceutical company that discovers develops, and markets both biopharmaceuticals and small molecule drugs, launched QULIPTATM (atonement) a prescription medicine for the preventative treatment of episodic migraine in adults. It is uniquely formulated with oral calcitonin gene-related peptide (CGRP) receptor antagonist (giant) in three dose sizes of 10 mg, 30 mg, and 60 mg which are approved by The U.S. Food and Drug Administration (FDA), a US-based department of health.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Headache Disorders Market Characteristics
3. Headache Disorders Market Trends And Strategies
4. Headache Disorders Market - Macro Economic Scenario
5. Headache Disorders Market Size And Growth
…..
27. Headache Disorders Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Headache Disorders Market Analysis 2024-2033 : Forecast Market Size, Top Segments And Largest Region | Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Novartis AG, Eli Lilly and Company here
News-ID: 3404413 • Views: …
More Releases from The Business Research Company
Laparoscopy Devices Market to Grow to $17.13 Billion by 2028, Fueled by Minimall …
The laparoscopy devices market size has grown strongly in recent years. It will grow from $12.17 billion in 2023 to $13.1 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to improved surgeon training programs, enhanced safety and efficacy, shift towards minimally invasive surgery, evolution in energy-based devices, early adoption challenges.
The laparoscopy devices market size is expected to…
Inventory Tags Market to Grow to $7.04 Billion by 2028, Fueled by Barcode Techno …
The inventory tags market size has grown steadily in recent years. It will grow from $5.55 billion in 2023 to $5.8 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to barcode technology adoption, development of rfid tags, manual inventory management systems, standardization of tagging systems, introduction of qr codes.
The inventory tags market size is expected to see…
Infection Control Market to Grow to $164.6 Billion by 2028: Major Trends, Techno …
The infection control market size has grown strongly in recent years. It will grow from $119.1 billion in 2023 to $126.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to healthcare-associated infections (hais), stringent regulatory standards, rising awareness of infectious diseases, globalization and travel, increased healthcare expenditure.
The infection control market size is expected to see strong growth…
Hyperpigmentation Disorder Market to Reach $7.73B by 2028 within Forecast Period …
The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.3 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to clinical trials and research, advances in chemical peels, cultural shift towards skincare, emphasis on non-invasive options, demand for natural products.
The hyperpigmentation disorder treatment market size is…
More Releases for Headache
Voice Assistants Lessening Headache of Contact Center Employees
A lot of people, both men and women, have either of two girlfriends they are increasingly talking to during the day: Siri and Alexa. In a short time, these voice assistants have become so popular that people often talk to them just for entertainment, asking pointless questions to hear even-more-pointless and often-hilarious answers. Moreover, voice assistants help people control the operations of electrical and electronic devices, such as TVs, home…
BCC-LITE – The New Solution to Interoperability Headache
Base Camp Connect has just launched the BCC-LITE, a rapid-deploy kit that provides a telephone system, an Internet access, and a radio interoperability gateway within minutes.
Quebec – September 20, 2017 - Communications failures account for 60% of all emergency-related issues. When that happens, public safety agencies are out of information, their intelligence fails, and that creates delays and confusion putting responders and the public in danger. To ensure continuous…
Cluster Headache Syndrome - Pipeline Review, H2 2017
"The Report Cluster Headache Syndrome - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cluster Headache Syndrome - Pipeline Review, H2 2017, provides an overview of the Cluster Headache Syndrome (Central Nervous System) pipeline landscape.
Cluster headache is pain that occurs along one side of the head. It…
Cluster Headache Syndrome Market: Industry Research and Analysis 2017
Global Cluster Headache Syndrome Market: Overview
Cluster headache is a neurological disorder. It is a condition characterized by recurrence of severe headache usually around the eye on one side of the head. Cluster headache, in most cases, is accompanied by excessive tears, nasal decongestion, and swelling of the eye. Individuals suffering from cluster headache syndrome might often have to endure agonizing attacks of unilateral headaches.
Get accurate market forecast and analysis on…
Cluster Headache Syndrome Market Intelligence Report Offers Growth Prospects
Cluster headache, a neurological disorder is a condition characterized by severe headaches recurring on one side of the head usually around the eye. Cluster headache is often accompanied by autonomic symptoms such as excessive tears, swelling of the eye and nasal decongestion. In cluster headache syndrome, individuals often suffer from excruciating attacks of unilateral headaches. Some symptoms like migraine such as sensitivity to light and sound, nausea may also…
Cluster Headache Syndrome - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title
Cluster Headache Syndrome - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cluster Headache Syndrome - Pipeline Review, H1 2017, provides an overview of the Cluster Headache Syndrome (Central Nervous System) pipeline landscape.
Cluster headache is pain that occurs along one side of the head. It is…
